Position in ANAB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,680,830
-$2,535,178 QoQ
Shares Held
39,716
-71.8% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
2.51%
of 13F equity value
Holder Rank
#64
of 211 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighMark Wealth Management LLC holds $13,360,619 across 36 Biotechnology names. ANAB ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
32,266 | $4,282,666 | |
| 2 | ANAB |
Anaptysbio, Inc
This page
|
39,716 | $2,680,830 | |
| 3 | EWTX |
Edgewise Therapeutics, Inc.
|
53,179 | $2,160,662 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
38,595 | $1,444,224 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
23,000 | $1,388,280 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
35,196 | $597,276 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
55,878 | $215,130 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
5,310 | $207,143 |
All Filings in ANAB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,680,830 | 39,716 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,216,008 | 94,050 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,559,544 | 94,050 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,135,224 | 135,050 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,231,210 | 145,550 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,710,275 | 92,000 | Shares | Sole | 2025-04-24 | |
| No filing history on record for this holder in this stock. | ||||||